Fig. 6From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE studyMedication Satisfaction Questionnairea Satisfaction with Current Injectable Medication Item, Paliperidone Palmitate Group. aPatients were asked, “How satisfied are you with your current injectable medication?” Possible responses were very dissatisfied, somewhat dissatisfied, neither, somewhat satisfied, or very satisfiedBack to article page